© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Product Name: Ulipristal Acetate
Chemical Formula: C30H37NO4
Synonyms: CDB-2914, Ella, Esmya
CAS Number: 126784-99-4
Recommended Use: Pharmaceutical synthesis, emergency contraception, uterine fibroid treatment
Supplier Identification: Pharmaceutical manufacturers, research laboratories, healthcare providers
Contact Information: Emergency telephone and company contact on product packaging and official documentation
Hazard Classification: Category 3 Reproductive Toxicity, Category 2 Acute Toxicity, Eye Irritation
Signal Word: Warning
Hazard Statements: May damage fertility, can harm unborn child, causes eye irritation, may cause allergic reactions or respiratory irritation
Pictograms: Health hazard symbol, exclamation mark
Precautionary Statements: Avoid breathing dust, wash hands thoroughly after handling, use only outdoors or in a well-ventilated area, wear protective gloves and eye protection, avoid release to the environment, seek medical advice if you feel unwell
Chemical Identity: Ulipristal Acetate
Concentration: 100% active pharmaceutical ingredient for pure substance; tablets or formulated products contain Ulipristal acetate in 5 mg or 30 mg doses along with inactive excipients
Impurities and Stabilizers: Pharmaceuticals may include cellulose, lactose monohydrate, magnesium stearate, and other inert materials
Ingredient Disclosure: Refer to product packaging or manufacturing specifications for details on all excipients present in a formulated product
Inhalation: Remove person to fresh air, monitor for respiratory distress, seek medical help if symptoms develop
Skin Contact: Remove any contaminated clothing, wash exposed skin with soap and water for several minutes, obtain medical attention for irritation or allergic reaction
Eye Contact: Rinse eyes gently with water for at least 15 minutes, remove contact lenses if possible, seek immediate medical evaluation
Ingestion: Seek medical attention right away, do not induce vomiting unless advised by medical personnel, rinse mouth with water only if patient is conscious
Most Important Symptoms: Respiratory irritation, dizziness, allergic skin reaction, gastrointestinal discomfort, possible effects on fertility or fetal development if ingested
Suitable Extinguishing Media: Use dry chemical, carbon dioxide, foam, or water spray
Unsuitable Extinguishing Media: Do not use water jets directly on burning powder
Special Hazards: Decomposition may produce toxic fumes like nitrogen oxides, carbon monoxide, carbon dioxide
Protective Equipment for Firefighters: Standard turnout gear, self-contained breathing apparatus, chemical resistant gloves and boots
Advice for Emergency Responders: Evacuate unnecessary personnel, prevent runoff from entering waterways, and cool adjacent containers with water spray
Personal Precautions: Wear lab coat, chemical-resistant gloves, safety eyewear, and respiratory mask if dust is present
Environmental Precautions: Avoid release into sewers, surface water, or soil
Containment: Collect spilled material using inert absorbent (e.g., sand or vermiculite), place in suitable waste container
Clean-up Procedures: Vacuum or sweep up residues, ventilate area, prevent dust formation, wash area with soap and water once cleanup is complete
Safe Handling Advice: Minimize dust generation and accumulation, avoid all unnecessary exposure, use only with adequate ventilation, do not eat or drink while handling
Storage Conditions: Store at controlled room temperature, ideally 20-25°C (68-77°F), protect from moisture, light, and incompatible substances
Storage Incompatibility: Keep away from strong oxidizers, acids, and excessive humidity
Packing Requirements: Use tightly sealed original containers, keep out of reach of unauthorized personnel, ensure that packaging is clearly labeled
Occupational Exposure Limits: No specific product exposure limits established, follow local workplace regulations
Engineering Controls: Employ fume hood, local exhaust ventilation, HEPA filtration systems in laboratory settings
Personal Protective Equipment: Wear nitrile gloves, safety goggles, laboratory coat, and respiratory protection in case of inadequate ventilation or significant airborne dust
Hygiene Measures: Wash hands, face, and exposed skin before breaks and at end of work shift, remove contaminated clothing and clean before reuse
Appearance: White to off-white powder or crystalline solid
Molecular Weight: 475.62 g/mol
Odor: Odorless
pH: No data available in pure form
Melting Point: Approximately 182-186°C (359-367°F)
Solubility: Practically insoluble in water, soluble in DMSO, methanol, ethanol, acetone
Partition Coefficient (log P): 4.5 (predicted)
Vapor Pressure: Not applicable (solid at RT)
Boiling Point: Decomposes before boiling
Flash Point: Not readily flammable
Auto-Ignition Temperature: No data
Density: Approximately 1.18 g/cm³
Chemical Stability: Stable under recommended storage and handling conditions
Reactivity: Inert to most standard laboratory reagents
Conditions to Avoid: Exposure to heat, direct sunlight, acids, strong bases and oxidizing agents, moisture
Hazardous Decomposition Products: Carbon monoxide, carbon dioxide, nitrogen oxides, other toxic fumes possible under fire conditions
Polymerization: Product does not undergo hazardous polymerization
Acute Toxicity: May cause gastrointestinal upset, dizziness, headache, mild skin irritation
Chronic Toxicity: Risk of reproductive toxicity, effects on menstrual cycle, and potential teratogenic effects with long-term or repeated ingestion
Routes of Exposure: Inhalation, dermal, oral, ocular
Carcinogenicity: Not classed as human carcinogen by IARC, ACGIH, or NTP
Mutagenicity: No substantial evidence in standard assays, but precaution advised for pharmaceutical workers
Reproductive Effects: Well documented to affect ovulation and uterine lining, contraindicated in pregnancy, risk for fetal toxicity
Sensitization: Potential for allergic skin or respiratory response in sensitive individuals
Other Data: No significant animal data available for high-dose or long-term effects outside reproductive endpoints
Ecotoxicity: Toxic to aquatic life with long-lasting effects in environmental exposure scenarios
Persistence and Degradability: Active pharmaceutical ingredient may persist in the environment; slow degradation
Bioaccumulation Potential: Moderate tendency for accumulation in aquatic and soil organisms
Mobility in Soil: Immobilized in high-organic soils, mobile in well-drained sandy media
Other Adverse Effects: Disruption of fish reproductive cycles predicted based on related compounds
Disposal Methods: Treat as hazardous pharmaceutical waste; collect in clearly marked containers, dispose of in accordance with local, regional, and national regulations
Contaminated Packaging: Incinerate under controlled conditions, do not reuse for other purposes
Waste Code: Refer to applicable waste disposal codes for pharmaceuticals or cytotoxic medications
Precautions: Wear appropriate PPE during collection and disposal, avoid release to drains or water systems
UN Number: Not classified as dangerous goods for most forms and routes, consult shipment documentation for specific local assignment
UN Proper Shipping Name: Ulipristal Acetate, pharmaceutical preparation
Transport Hazard Class: None assigned for medical products in finished forms
Packing Group: Not applicable
Environmental Hazards: Not a marine pollutant at finished formulation concentrations, open powder poses risk if released
Special Precautions: Transport in secure, sealed packaging, avoid mixture with incompatible materials, handle with care
Safety, Health, and Environmental Regulations: Subject to regulation under regional pharmaceutical controls such as EMA, FDA, Health Canada
Labelling Requirements: Pharmaceutical labeling includes composition, usage instructions, hazard indicators and disposal guidance
Chemical Inventory Listing: Registered with most national medicine agencies under specific CAS number
Worker Protection Codes: Regulated in occupational settings with safety data sheet disclosure and training mandate in place
Restrictions on Use: Restricted to prescription-only use in most countries, not for use during pregnancy, use by trained medical staff
Additional Guidance: Refer to national and local pharmaceutical safety agencies for site-specific regulatory obligations
